Ascentis Independent Advisors

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1845003 DALLAS, TX

Position in MIRM

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$1,790,324

+$259,498 QoQ

Shares Held

19,380

0.0% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Ascentis Independent Advisors holds $2,720,776 across 46 Biotechnology names. MIRM ranks #1 (65.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc. This page	19,380	$1,790,324
2	REGN	Regeneron Pharmaceuticals, Inc.	476	$367,774
3	INSM	INSMED Inc	743	$121,494
4	VRTX	Vertex Pharmaceuticals Inc / Ma	161	$71,890
5	ALNY	Alnylam Pharmaceuticals, Inc.	194	$64,187
6	LCTX	Lineage Cell Therapeutics, Inc.	30,912	$48,840
7	SGMOQ	Sangamo Therapeutics, Inc	180,500	$45,125
8	CRDF	Cardiff Oncology, Inc.	24,500	$39,690

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,790,324	19,380	0.0%	Shares	Sole	2026-04-28
2025-12-31	$1,530,826	19,380	0.0%	Shares	Sole	2026-01-29
2025-09-30	$1,420,747	19,380	0.0%	Shares	Sole	2025-10-21
2025-06-30	$986,248	19,380	0.0%	Shares	Sole	2025-07-14
2025-03-31	$873,069	19,380	0.0%	Shares	Sole	2025-04-23
2024-12-31	$801,363	19,380	+1390.8%	Shares	Sole	2025-01-24
2024-09-30	$50,700	1,300	-93.5%	Shares	Sole	2024-10-29
2024-06-30	$681,406	19,930	+5.3%	Shares	Sole	2024-07-29
2023-12-31	$558,813	18,930	+5.3%	Shares	Sole	2024-02-02
2023-09-30	$568,168	17,980	0.0%	Shares	Sole	2023-10-20
2023-06-30	$465,142	17,980	0.0%	Shares	Sole	2023-07-19
2023-03-31	$431,879	17,980	-4.0%	Shares	Sole	2023-06-01
2022-03-31	$412,434	18,730	0.0%	Shares	Sole	2022-05-18
2021-12-31	$298,743	18,730	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.